Megalencephalic Leukoencephalopathy With Subcortical Cysts synonyms

Megalencephalic Leukoencephalopathy With Subcortical Cysts (MLC) is a rare genetic disorder that primarily affects the brain and spinal cord. It is also known by several other names, including Van der Knaap disease, Van der Knaap syndrome, and MLC1 disease.

MLC is characterized by the presence of subcortical cysts (fluid-filled spaces) in the brain's white matter, which is responsible for transmitting signals between different regions of the brain. These cysts can cause progressive damage to the white matter, leading to various neurological symptoms.

Individuals with MLC may experience a range of symptoms, including developmental delay, motor abnormalities, seizures, ataxia (lack of muscle coordination), and cognitive impairment. The age of symptom onset and disease progression can vary widely among affected individuals.

MLC is caused by mutations in specific genes that are involved in the production of proteins necessary for the normal functioning of brain cells. The most common genetic mutations associated with MLC occur in the MLC1 gene, but mutations in other genes such as HEPACAM and GLIALCAM have also been identified.

Diagnosis of MLC typically involves a combination of clinical evaluation, brain imaging studies, and genetic testing. Magnetic resonance imaging (MRI) can reveal the characteristic subcortical cysts and white matter abnormalities. Genetic testing can confirm the presence of mutations in the associated genes.

Unfortunately, there is currently no cure for MLC. Treatment mainly focuses on managing symptoms and providing supportive care. This may include physical therapy, occupational therapy, speech therapy, and medications to control seizures or other symptoms.

Research efforts are ongoing to better understand the underlying mechanisms of MLC and develop potential therapies. Gene therapy and other experimental approaches hold promise for the future.